Biotage AB Statistics

Total Valuation

Biotage AB has a market cap or net worth of SEK 15.79 billion. The enterprise value is 15.72 billion.

Market Cap	15.79B
Enterprise Value	15.72B

Important Dates

The last earnings date was Thursday, August 29, 2024.

Earnings Date	Aug 29, 2024
Ex-Dividend Date	Apr 26, 2024

Share Statistics

Biotage AB has 80.05 million shares outstanding. The number of shares has increased by 19.45% in one year.

Shares Outstanding	80.05M
Shares Change (YoY)	+19.45%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	65.94%
Float	66.00M

Valuation Ratios

The trailing PE ratio is 62.85 and the forward PE ratio is 49.91. Biotage AB's PEG ratio is 2.90.

PE Ratio	62.85
Forward PE	49.91
PS Ratio	7.60
PB Ratio	4.16
P/FCF Ratio	46.29
PEG Ratio	2.90

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.35, with an EV/FCF ratio of 46.10.

EV / Earnings	62.64
EV / Sales	7.57
EV / EBITDA	30.35
EV / EBIT	42.38
EV / FCF	46.10

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 6.70.

Current Ratio	1.88
Quick Ratio	1.14
Debt / Equity	6.70
Debt / EBITDA	0.49
Debt / FCF	0.74
Interest Coverage	9.05

Financial Efficiency

Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 5.68%.

Return on Equity (ROE)	6.66%
Return on Assets (ROA)	4.71%
Return on Capital (ROIC)	5.68%
Revenue Per Employee	3.11M
Profits Per Employee	376,312
Employee Count	674
Asset Turnover	0.42
Inventory Turnover	1.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.27% in the last 52 weeks. The beta is 0.86, so Biotage AB's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+66.27%
50-Day Moving Average	182.77
200-Day Moving Average	163.00
Relative Strength Index (RSI)	59.10
Average Volume (20 Days)	55,954

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotage AB had revenue of SEK 2.08 billion and earned 251.00 million in profits. Earnings per share was 3.14.

Revenue	2.08B
Gross Profit	1.30B
Operating Income	371.00M
Pretax Income	313.00M
Net Income	251.00M
EBITDA	488.00M
EBIT	371.00M
Earnings Per Share (EPS)	3.14

Full Income Statement

Balance Sheet

The company has 318.00 million in cash and 254.00 million in debt, giving a net cash position of 64.00 million or 0.80 per share.

Cash & Cash Equivalents	318.00M
Total Debt	254.00M
Net Cash	64.00M
Net Cash Per Share	0.80
Equity (Book Value)	3.79B
Book Value Per Share	47.36
Working Capital	563.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 399.00 million and capital expenditures -58.00 million, giving a free cash flow of 341.00 million.

Operating Cash Flow	399.00M
Capital Expenditures	-58.00M
Free Cash Flow	341.00M
FCF Per Share	4.26

Full Cash Flow Statement

Margins

Gross margin is 62.73%, with operating and profit margins of 17.86% and 12.08%.

Gross Margin	62.73%
Operating Margin	17.86%
Pretax Margin	15.07%
Profit Margin	12.08%
EBITDA Margin	23.50%
EBIT Margin	17.86%
FCF Margin	16.42%

Dividends & Yields

This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 0.81%.

Dividend Per Share	1.60
Dividend Yield	0.81%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	51.00%
Buyback Yield	-19.45%
Shareholder Yield	-18.64%
Earnings Yield	1.59%
FCF Yield	2.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a